Not finding it? Sign in to also search OpenAlex live.
-
Rebel with a cause: The effects of leadership encouragement and psychological safety on professionals' prosocial r ulebreaking behavior2023 Public Administration article Business, Management and Accounting Job Satisfaction and Organizational Behavior Open access
Bernard Bernards, Eduard J.E.T. Schmidt, Sandra M. Groeneveld
18citations -
Clinical predictors and neural correlates for compromised swallowing safety in Huntington disease2021 European Journal of Neurology article Health Professions Dysphagia Assessment and Management Open access
Beate Schumann‐Werner, Imis Dogan, Shahram Mirzazade, Bettina Mall, Rena Overbeck, Philipp Honrath, +3 more
18citations -
CROCuS, a Phase II Study Evaluating the Antiviral Activity, Clinical Outcomes, and Safety of Rilematovir in Children Aged ≥ 28 Days and ≤ 3 Years with Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus
Fernando Ferrero, Chien‐Yu Lin, Johannes G. Liese, Kléber Giovanni Luz, T. Stoeva, Ágnes Németh, +14 more
15citations -
Long‐term safety and efficacy of filgotinib for the treatment of moderately to severely active ulcerative colitis: Interim analysis from up to 4 years of follow‐up in the SELECTION open‐label long‐term extension study2024 Alimentary Pharmacology & Therapeutics article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Brian G. Feagan, Katsuyoshi Matsuoka, Gerhard Rogler, David Laharie, Severine A.R.A. Vermeire, Silvio Danese, +9 more
14citations -
First‐in‐human trial to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of STR‐324, a dual enkephalinase inhibitor for pain management2021 British Journal of Clinical Pharmacology article Medicine Pain Mechanisms and Treatments Open access
Laurence M. Moss, Cécile L. Berends, Emilie M.J. van Brummelen, Ingrid M. C. Kamerling, Erica Surya Klaassen, Kirsten Riber Bergmann, +4 more
11citations -
ESMO-ESTRO consensus statements on the safety of combining radiotherapy with CDK4/6, HER2, PARP, or mTOR inhibitors2025 Radiotherapy and Oncology article Physics and Astronomy Advanced Radiotherapy Techniques Open access
Evert S.M. van Aken, Ajeet Kumar Gandhi, Sean Michael O'Cathail, Gerben R. Borst, Jorge Barriuso, Emmanouil Fokas, +26 more
10citations -
Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Antitumor Activity of the Cyclin-Dependent Kinase-9 (CDK9) Inhibitor AZD4573 in Relapsed/Refractory Hematological Malignancies: A Phase 1 First-in-Human Study
Tim H. Brümmendorf, Patrick G. Medd, Raphael Koch, Stephan Stilgenbauer, Shringi Sharma, Yun He, +4 more
8citations -
Maximizing Treatment Opportunities: Assessing Protocol Waivers’ Impact on Safety and Outcome in the Drug Rediscovery Protocol2024 Clinical Cancer Research article Mathematics Statistical Methods in Clinical Trials Open access
Jade M. van Berge Henegouwen, Laurien Joanna Zeverijn, Birgit S. Geurts, Louisa Rose Hoes, Hanneke van der Wijngaart, Vincent van der Noort, +7 more
2citations -
Process-evaluation of the implementation of a collaborative community programme for health, safety and talent development in youth2026 Children and Youth Services Review article Health Professions Health Policy Implementation Science Open access
Mirte Boelens, Harrie Jonkman, Clemens M. H. Hosman, Hein Raat, Wilma Jansen
0citations -
A first-in-human, phase 1 dose escalation and expansion study evaluating the safety, tolerability, and anti-tumor activity of [225Ac]Ac-FL-020, an anti-PSMA radioconjugate, in patients with metastatic castration-resistant prostate cancer (mCRPC).
Andrei H. Iagaru, GIUSEPPE T. CARDACI, Aaron Richard Hansen, Jeffrey Y.C. Wong, Carlos Artigas, Karolien E. Goffin, +7 more
0citations -
Long‐Term Efficacy, Safety, and Tolerability of Alirocumab in 8242 Patients Eligible for 3 to 5 Years of Placebo‐Controlled Observation in the ODYSSEY OUTCOMES Trial2023 Journal of the American Heart Association article Medicine Lipoproteins and Cardiovascular Health Open access
Shaun G. Goodman, Philippe Gabríel Steg, Yann Poulouin, Deepak L. Bhatt, Vera Bittner, Rafael Díaz, +8 more
43citations -
Pregnancy outcomes following periconceptional or gestational exposure to ustekinumab: Review of cases reported to the manufacturer's global safety database2022 Alimentary Pharmacology & Therapeutics article Medicine Pregnancy and Medication Impact Open access
Uma Mahadevan, Saule Naureckas, Ilia Tikhonov, Yiting Wang, Connie B. Lin, Anja B. Geldhof, +1 more
31citations -
Safety, Immunogenicity, and Regimen Selection of Ad26.RSV.preF–Based Vaccine Combinations: A Randomized, Double-blind, Placebo-Controlled, Phase 1/2a Study2023 The Journal of Infectious Diseases article Medicine Respiratory viral infections research Open access
Christy A. Comeaux, Stephan Bart, Arangassery Rosemary Bastian, V. G. Klyashtorny, Els De Paepe, Edmund V Ekoka Omoruyi, +5 more
21citations -
Effect of Age on the Efficacy and Safety of Single Agent Oral Selinexor in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL): A Post-Hoc Analysis of the Sadal Pivotal Study
Michael W. Schuster, Miguel Ángel Canales, Jason R. Westin, Josée M. Zijlstra, George Follows, Reem Karmali, +32 more
3citations -
Diagnostic Yield and Safety of Invasive Coronary Function Testing After Radial Versus Femoral Access2026 Circulation Cardiovascular Interventions article Medicine Vascular Procedures and Complications Open access
Fleur W Adriaansen, Caïa Crooijmans, Tijn P.J. Jansen, Behruz Yosofi, Joan Gerard Meeder, Yolande Appelman, +25 more
3citations -
120. Safety, Reactogenicity, and Immunogenicity of Three Different Doses of VAC52416 (ExPEC10V) in Adults Aged 60–85 Years in a Randomized, Multicenter, Interventional, First-In-Human, Phase 1/2a Study2022 Open Forum Infectious Diseases article Biochemistry, Genetics and Molecular Biology Escherichia coli research studies Open access
Joachim Doua, Carlos A. Fierro, Michal Sarnecki, Bart Spiessens, Oscar T. Go, Todd A. Davies, +3 more
2citations -
NeflgArd Open-Label Extension: Efficacy and Safety of Nefecon in Patients with IgAN Who Completed the 2-Year Phase 3 Trial2024 Journal of the American Society of Nephrology article Medicine Renal Diseases and Glomerulopathies
Richard A. Lafayette, Jens Halkjaer Kristensen, Russell F Jones, Jürgen Floege, Vladimı́r Tesař, Hernán Trimarchi, +4 more
2citations -
LB001EFFICACY AND SAFETY OF BELIMUMAB IN PATIENTS WITH ACTIVE LUPUS NEPHRITIS: A PHASE 3, RANDOMISED, PLACEBO-CONTROLLED TRIAL2020 Nephrology Dialysis Transplantation article Medicine Systemic Lupus Erythematosus Research Open access
Brad H. Rovin, Frédéric Houssiau, Richard Alan Furie, Ana Malvar, Y K Onno Teng, Chi Chiu Mok, +10 more
2citations -
#2028 Efficacy and safety of sucroferric oxyhydroxide versus sevelamer carbonate: a systematic review and meta-analysis2024 Nephrology Dialysis Transplantation article Medicine Parathyroid Disorders and Treatments Open access
Christos Georgopoulos, Αnila Duni, Eleni Stamellou, Αθανάσιος Κίτσος, Charikleia Gouva, Evangelia Ntounousi
1citations